These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16246662)

  • 21. A randomized comparative study on vaginal administration of acetic acid-moistened versus dry misoprostol for mid-trimester pregnancy termination.
    Bhattacharjee N; Saha SP; Ganguly RP; Patra KK; Jha T; Barui G; Saha M
    Arch Gynecol Obstet; 2012 Feb; 285(2):311-6. PubMed ID: 21735193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized trial comparing oral misoprostol with intra-amniotic prostaglandin F2alpha for second trimester terminations.
    Marquette GP; Skoll MA; Dontigny L
    J Obstet Gynaecol Can; 2005 Nov; 27(11):1013-8. PubMed ID: 16529667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequent low-dose misoprostol for termination of second-trimester pregnancy.
    Dilbaz S; Caliskan E; Dilbaz B; Kahraman BG
    Eur J Contracept Reprod Health Care; 2004 Mar; 9(1):11-5. PubMed ID: 15352690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between gestational age and induction-to-abortion interval in mid-trimester pregnancy termination using misoprostol.
    Vitner D; Deutsch M; Paz Y; Khatib N; Baltiter T; Rosenberg S; Lowenstein L
    Eur J Obstet Gynecol Reprod Biol; 2011 Jun; 156(2):140-3. PubMed ID: 21507550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison between two doses of intravaginal misoprostol and gemeprost for induction of second-trimester abortion.
    Nuutila M; Toivonen J; Ylikorkala O; Halmesmäki E
    Obstet Gynecol; 1997 Dec; 90(6):896-900. PubMed ID: 9397098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of second trimester abortion (12-20 weeks) with mifepristone and misoprostol: a review of 386 consecutive cases.
    Goh SE; Thong KJ
    Contraception; 2006 May; 73(5):516-9. PubMed ID: 16627037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Buccal misoprostol as cervical preparation for second trimester pregnancy termination.
    Todd CS; Soler M; Castleman L; Rogers MK; Blumenthal PD
    Contraception; 2002 Jun; 65(6):415-8. PubMed ID: 12127640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Second-trimester pregnancy termination with 600-microg vs. 400-microg vaginal misoprostol and systematic curettage postexpulsion: a randomized trial.
    Carbonell JL; Torres MA; Reyes R; Ortega L; García-Gallego F; Sánchez C
    Contraception; 2008 Jan; 77(1):50-5. PubMed ID: 18082667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized controlled trial of misoprostol for second-trimester pregnancy termination associated with fetal malformation.
    Akoury HA; Hannah ME; Chitayat D; Thomas M; Winsor E; Ferris LE; Einarson TR; Seaward PG; Ryan G; Willan AR; Windrim R
    Am J Obstet Gynecol; 2004 Mar; 190(3):755-62. PubMed ID: 15042010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaginal versus oral misoprostol for second-trimester pregnancy termination: a randomized trial.
    Behrashi M; Mahdian M
    Pak J Biol Sci; 2008 Nov; 11(21):2505-8. PubMed ID: 19205272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Misoprostol for termination of pregnancy with intrauterine fetal demise in the second and third trimester of pregnancy - a systematic review.
    Gómez Ponce de León R; Wing DA
    Contraception; 2009 Apr; 79(4):259-71. PubMed ID: 19272495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaginal misoprostol in termination of second trimester pregnancy.
    Herabutya Y; Chanrachakul B; Punyavachira P
    J Obstet Gynaecol Res; 2000 Apr; 26(2):121-5. PubMed ID: 10870304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the efficacy and safety of two combined misoprostol regimens for second trimester medical abortion.
    Kalogiannidis I; Tsakiridis I; Dagklis T; Kapetanios G; Mamopoulos A; Athanasiadis A
    Eur J Contracept Reprod Health Care; 2021 Feb; 26(1):42-47. PubMed ID: 33044101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of two regimens of intravaginal misoprostol for termination of second trimester pregnancy: a randomized comparative trial.
    Wong KS; Ngai CS; Yeo EL; Tang LC; Ho PC
    Hum Reprod; 2000 Mar; 15(3):709-12. PubMed ID: 10686224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomised comparative study on sublingual versus vaginal administration of misoprostol for termination of pregnancy between 13 to 20 weeks.
    Bhattacharjee N; Saha SP; Ghoshroy SC; Bhowmik S; Barui G
    Aust N Z J Obstet Gynaecol; 2008 Apr; 48(2):165-71. PubMed ID: 18366490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Efficacy and safety of mifepristone combined with misoprostol for termination of pregnancy between 8 and 16 weeks of gestation].
    Qian J; Jing X; Wu S; Zheng S; Li Y; Ren M; Di W; Shen H; Dong B; Chang Q; Shi H; Yao C; Song W; Huang Z
    Zhonghua Fu Chan Ke Za Zhi; 2015 Jul; 50(7):505-9. PubMed ID: 26311640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Buccal misoprostol plus laminaria for cervical preparation before dilation and evacuation at 21-23 weeks of gestation: a randomized controlled trial.
    Drey EA; Benson LS; Sokoloff A; Steinauer JE; Roy G; Jackson RA
    Contraception; 2014 Apr; 89(4):307-13. PubMed ID: 24560477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of two dosing regimens of intravaginal misoprostol for second-trimester pregnancy termination.
    Jain JK; Kuo J; Mishell DR
    Obstet Gynecol; 1999 Apr; 93(4):571-5. PubMed ID: 10214835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective randomised comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy.
    Tang OS; Lau WN; Chan CC; Ho PC
    BJOG; 2004 Sep; 111(9):1001-5. PubMed ID: 15327617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two regimens of vaginal misoprostol in second trimester termination of pregnancy: a prospective randomised trial.
    Bhattacharyya SK; Mukherji J; Kamilya GS; Ray S; Hazra A
    Acta Obstet Gynecol Scand; 2006; 85(12):1458-62. PubMed ID: 17260222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.